Wen Ni

1.6k total citations · 1 hit paper
18 papers, 1.2k citations indexed

About

Wen Ni is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wen Ni has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Wen Ni's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer-related gene regulation (3 papers). Wen Ni is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer-related gene regulation (3 papers). Wen Ni collaborates with scholars based in China, United States and Germany. Wen Ni's co-authors include Aijun Zhou, Yunxia Zhou, Liheng Che, Piao Huang, Yuanyuan Liu, Su Yao, Jianming Li, Jingwen Liu, Yi� Ding and Longhua Chen and has published in prestigious journals such as PLoS ONE, Kidney International and American Journal Of Pathology.

In The Last Decade

Wen Ni

17 papers receiving 1.1k citations

Hit Papers

Long noncoding RNA GAS5 inhibits progression of colorecta... 2019 2026 2021 2023 2019 100 200 300 400

Peers

Wen Ni
Weihua Li China
Qiong Xu China
Lu Zang China
Dequan Wu China
Geyan Wu China
Wen Ni
Citations per year, relative to Wen Ni Wen Ni (= 1×) peers Haifeng Zhang

Countries citing papers authored by Wen Ni

Since Specialization
Citations

This map shows the geographic impact of Wen Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Ni more than expected).

Fields of papers citing papers by Wen Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Ni. The network helps show where Wen Ni may publish in the future.

Co-authorship network of co-authors of Wen Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Ni. A scholar is included among the top collaborators of Wen Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Ni. Wen Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Xu, Yuanyuan, Chao Qin, Qi Wu, et al.. (2025). NSUN5 Mediates Resistance to Doxorubicin via Up-regulation of DNA Damage Repair Proteins BRCA2 and BRIP1 in Colorectal Cancer. American Journal Of Pathology. 195(10). 1921–1935. 1 indexed citations
2.
Ni, Wen, Yuanyuan Xu, Yuqing Li, et al.. (2025). Lipid deposition promotes YTHDF3-mediated m6A modification of PPARα to facilitate liver metastasis of colorectal cancer. Protein & Cell. 17(3). 190–211.
4.
Zhou, Rong, Wen Ni, Chao Qin, et al.. (2022). A functional loop between YTH domain family protein YTHDF3 mediated m6A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 41(1). 334–334. 42 indexed citations
5.
Zhu, Hongtao, Xueqing Liu, Yuan Ding, et al.. (2022). IL-6 coaxes cellular dedifferentiation as a pro-regenerative intermediate that contributes to pericardial ADSC-induced cardiac repair. Stem Cell Research & Therapy. 13(1). 44–44. 14 indexed citations
6.
Ni, Wen, Hui Mo, Yuanyuan Liu, et al.. (2021). Targeting cholesterol biosynthesis promotes anti-tumor immunity by inhibiting long noncoding RNA SNHG29-mediated YAP activation. Molecular Therapy. 29(10). 2995–3010. 73 indexed citations
7.
Che, Liheng, Jingwen Liu, Jian-Ping Huo, et al.. (2021). A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy. Cell Discovery. 7(1). 80–80. 118 indexed citations
8.
Ni, Wen, Su Yao, Yunxia Zhou, et al.. (2019). Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3. Molecular Cancer. 18(1). 143–143. 465 indexed citations breakdown →
9.
Zhang, Yu‐Qin, Jing Huang, Qisheng Li, et al.. (2018). Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma. BMC Cancer. 18(1). 539–539. 39 indexed citations
10.
Ni, Wen, Yuqin Zhang, Ye Feng, et al.. (2017). A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. Journal of Hematology & Oncology. 10(1). 91–91. 179 indexed citations
11.
Liang, Yonghao, Qisheng Li, Keli Chen, et al.. (2017). Zinc finger protein 307 functions as a tumor-suppressor and inhibits cell proliferation by inducing apoptosis in hepatocellular carcinoma. Oncology Reports. 38(4). 2229–2236. 9 indexed citations
12.
Zhang, Jianfeng, et al.. (2015). Transplantation of mouse embryonic stem cell-derived oligodendrocytes in the murine model of globoid cell leukodystrophy. Stem Cell Research & Therapy. 6(1). 30–30. 21 indexed citations
13.
Liu, Ying, Yi� Ding, Jing Huang, et al.. (2014). MiR-141 Suppresses the Migration and Invasion of HCC Cells by Targeting Tiam1. PLoS ONE. 9(2). e88393–e88393. 84 indexed citations
15.
Yi, Nan, et al.. (2014). High expression of peroxiredoxin 4 affects the survival time of colorectal cancer patients, but is not an independent unfavorable prognostic factor. Molecular and Clinical Oncology. 2(5). 767–772. 29 indexed citations
16.
Ni, Wen, et al.. (2011). Association of genetic polymorphisms of CYP 2C19 with hypertension in a Chinese Han population. Blood Pressure. 20(3). 166–170. 13 indexed citations
17.
Eustace, Joseph A., et al.. (2005). Influence of Intravenous Drug Abuse on Vascular Access Placement and Survival in HIV-Seropositive Patients. Nephron Clinical Practice. 100(2). c38–c45. 8 indexed citations
18.
Haas, Mark, Edward S. Kraus, Milagros Samaniego, et al.. (2002). Acute renal allograft rejection with intimal arteritis: Histologic predictors of response to therapy and graft survival. Kidney International. 61(4). 1516–1526. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026